As of 2026-09-11, the EV/EBITDA ratio of agilon health Inc (AGL) is -8.96. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AGL's latest enterprise value is 1,467.68 mil USD. AGL's TTM EBITDA according to its financial statements is -163.71 mil USD. Dividing these 2 quantities gives us the above AGL EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.4x - 13.2x | 12.1x |
| Forward P/E multiples | 14.3x - 14.7x | 14.5x |
| Fair Price | (135.35) - (125.14) | (125.93) |
| Upside | -246.2% - -235.1% | -236.0% |
| Date | EV/EBITDA |
| 2026-09-04 | -8.55 |
| 2026-09-03 | -8.34 |
| 2026-09-02 | -8.43 |
| 2026-09-01 | -8.44 |
| 2026-08-31 | -8.49 |
| 2026-08-28 | -8.96 |
| 2026-08-27 | -9.13 |
| 2026-08-26 | -9.28 |
| 2026-08-25 | -9.32 |
| 2026-08-24 | -9.09 |
| 2026-08-21 | -9.37 |
| 2026-08-20 | -8.98 |
| 2026-08-19 | -9.07 |
| 2026-08-18 | -9.25 |
| 2026-08-17 | -9.40 |
| 2026-08-14 | -9.40 |
| 2026-08-13 | -8.59 |
| 2026-08-12 | -8.32 |
| 2026-08-11 | -8.33 |
| 2026-08-10 | -9.39 |
| 2026-08-07 | -9.26 |
| 2026-08-06 | -8.38 |
| 2026-08-05 | -10.52 |
| 2026-08-04 | -9.19 |
| 2026-08-03 | -9.12 |
| 2026-07-31 | -8.86 |
| 2026-07-30 | -9.39 |
| 2026-07-29 | -8.97 |
| 2026-07-28 | -9.63 |
| 2026-07-27 | -9.56 |
| 2026-07-24 | -9.52 |
| 2026-07-23 | -9.75 |
| 2026-07-22 | -11.74 |
| 2026-07-21 | -12.35 |
| 2026-07-20 | -11.97 |
| 2026-07-17 | -12.76 |
| 2026-07-16 | -11.88 |
| 2026-07-15 | -12.19 |
| 2026-07-14 | -12.02 |
| 2026-07-13 | -11.33 |
| 2026-07-10 | -11.23 |
| 2026-07-09 | -11.32 |
| 2026-07-08 | -10.92 |
| 2026-07-07 | -10.48 |
| 2026-07-06 | -10.49 |
| 2026-07-02 | -10.84 |
| 2026-07-01 | -10.92 |
| 2026-06-30 | -10.45 |
| 2026-06-29 | -11.26 |
| 2026-06-26 | -11.68 |